Revenue from operations rose 10.2% year on year (YoY) to Rs 2,745 crore in the quarter ended 31 March 2024.

Profit before tax was at Rs 631 crore, up 45.73% from Rs 433 crore posted in Q4 FY23.

Operating EBITDA stood at Rs 883 crore in Q4 FY24, registering the growth of 21% as against Rs 727 crore reported in Q4 FY23. Operating EBITDA margin improved to 32% as compared to 29% registered in the same period a year ago.

The company's India revenue grew by 10% YoY to Rs 1,380 crore in Q4 FY24. As per All India Organization of Chemists & Druggists (AIOCD) secondary market data, IPM growth for the quarter was 9%. Torrent’s chronic business grew at 14% versus IPM growth of 12%.

Torrent Pharma's Brazil revenue increased by 17% to Rs 372 crore and on constant currency terms rev...

• 

  (17 Jun 2024 17:15)

  Vishnu Prakash bags LoA for Rs 91-crore railway project
• 

  (17 Jun 2024 16:49)

  Butterfly Gandhimathi appoints Swetha Sagar as manager & CBO
• 

  (17 Jun 2024 15:50)

  Nandan Denim board OKs 1:10 stock split
• 

  (17 Jun 2024 14:07)

  Coromandel Intl inks MoU with NBSS&LUP to develop soil test in Maharashtra